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A platypus is a duck designed by a committee.
(Australian aphorism)
Practice guidelines should be enormously helpful to our
patients. We offer another view, however, to that expressed
by authors of the Surviving Sepsis Campaign (SSC) [1].
Traditionally, clinical decisions have been informed by peers,
but committees such as the SSC seek to drive, rather than
reflect, consensus. Is criticism of this new approach justified?
Guidelines can influence physicians to act against their better
judgement. For example, while only 47% of surveyed
intensivists believed that central venous pressure should
guide resuscitation, 86% used it because of the SSC
recommendation [2]. Protocols may improve care, but what
should one do when audited patient outcomes are already
better than those achieved by guideline interventions – such
as early goal-directed therapy for severe sepsis [3]?
Guidelines for high-income countries may be inappropriate
elsewhere, where assigning resources to guideline com-
pliance might preclude other interventions. Such prioritisation
is better determined by clinicians in response to local
circumstances than by international expert panels. When
guidelines become a standard of care, equipoise for
confirmatory trials can be lost. Enrolment in the Cortico-
steroid Therapy of Septic Shock (CORTICUS) trial [4], for
example, may have been unsustainably low because cortico-
steroids had the SSC imprimatur. Guidelines are increasingly
used in malpractice litigation despite contrary recommen-
dations. Finally, without the assent of clinicians, inappro-
priately formulated guidelines risk being ignored.
We suggest an alternative. Guidelines should define broad
goals rather than dictate exact replication of process. For
example, instead of recommending rigorous early goal-
directed therapy implementation, a guideline could
summarise the evidence, and then discuss the merits of
approaches (such as fluid therapy, blood transfusion, and
inotropic support) targeting central venous oxygen saturation
>70%. Rather than recommending strict glycaemic control, a
guideline might discuss the populations in which trials have
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Figure 1
Carte réduite de L’Australasie (“Smaller map of Australia”) by Robert
Gilles de Vaugondy, published in 1756. More than a list of directions,
declaring the unknown as well as the known aids safety and stimulates
discovery. National Library of Australia, Canberra, ACT 2600, Australia
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been performed and advise that, pending further evidence, a
reasonable strategy might be to control glucose to a degree,
but not so intensively as to cause hypoglycaemia.
Furthermore, as patrician democracy has given way to
universal suffrage, we envisage polls to gain the assent of
practising intensivists, such that guidelines reflect true
consensus rather than expert opinion. Quality assurance
standards – the broadly agreed minimum – should be
specifically distinguished from such guidelines.
We sense unease, inside and outside the profession [5], at
the list of directions presented by the ‘cartographer’ experts
of the SSC – made more contentious because the geo-
graphic features are incompletely known. Our suggestion is
analogous to replacing a recommended course with the
entire map, marked with areas of certainty and uncertainty
(Figure 1). Experience, local conditions, and resources should
determine the course of competent practitioners.
Authors’ response – A guide to the guide to the guidelines: staying afloat in turbulent seas
John C Marshall and Jean-Louis Vincent
A platypus is a strange-looking animal 
found only in Australia.
We appreciate the comments of Reade and colleagues. They
underline important points we made: ‘Guidelines are not rules
and do not preclude the clinician’s prerogative to make
specific decisions … that may be inconsistent with general
recommendations’ and ‘… the purpose of this guidelines
process has never been to constrain those who provide
exemplary care’ [1]. Moreover, we agree with the importance
of garnering the collective diverse views of clinicians; the
SSC guidelines involved 55 representatives of 16 different
endorsing organisations, and quantified the extent of con-
sensus on the recommendations [6].
We are therefore surprised at the authors’ discomfort with
the process and the product. Surely Australian intensivists
are not so meek they would apply a guideline to the detriment
of their patient, and do so because they fear litigation. Nor do
guidelines preclude further research. Since the 2004
publication that recommended tight glucose control in sepsis
[7], both the Efficacy of Volume Substitution and Insulin
therapy in Severe Sepsis (VISEP) trial and the Normo-
glycaemia in Intensive care Evaluation and Survival Using
Glucose Algorithm (NICE-SUGAR) trial have been com-
pleted, readdressing that very question. New trials on the
efficacy of goal-directed therapy and of activated protein C
are underway. It seems more plausible that guidelines pro-
mote high-quality research, by better framing the contem-
porary question.
Platypuses notwithstanding, there is nothing inexorably
unique about the Australian experience. Australian patients
could benefit from the collective, often conflicting, and
unquestionably imperfect international interpretation of the
sepsis literature that informs the SSC guidelines; patients
and clinicians around the world would gain more from their
engagement in the process of democratic debate than from
their sniping from the sidelines. Join us in this initiative, and
help to map the future.
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